Hyperkalemia in Chronic Kidney Disease: What is the Impact on Blood Pressure Control and CKD Progression?

This activity will address the common electrolyte disorder of hyperkalemia in CKD. Content will review pathophysiology and risk factors associated with hyperkalemia. Clinical evidence supporting treatment strategies for the management of hyperkalemia will also be presented. Finally, the program will address how a cation exchange potassium binder might impact patient care with regard to potassium concentration, blood pressure and aldosterone levels.

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Recall the epidemiology and etiology of hyperkalemia to better address CKD patient needs
  • Identify the risk of potassium retention with the use of RAAS inhibitors in patients with CKD and the impact on achieving therapeutic goals
  • Evaluate treatment options for hyperkalemia induced by RAAS inhibitors in patients with CKD to promote optimal patient outcomes

Target Audience

  • Physician
  • Nurse
  • Pharmacist
  • Family Physician
  • Physician Assistant
  • Nurse Practitioner
  • Dietitian
Accreditation/Designation of Credit Statements:

The National Kidney Foundation is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TMPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse

Awarded 1.0 contact hours of continuing nursing education (includes 0.0 contact hours in the area of pharmacology).

Pharmacist

This application-based enduring activity has been assigned ACPE Universal Activity Number 0620-0000-17-002-H01-P, for 1.0 contact hours (0.10 CEUs). The activity is available for credit through February 17, 2018. To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Family Physician

This enduring material activity Hyperkalemia in Chronic Kidney Disease: What is the Impact on Blood Pressure Control and CKD Progression? has been reviewed and is acceptable for up to 1.0 Prescribed credit(s) by the American Academy of Family Physicians.  Term of credit begins February 17, 2017.  Term of approval is for one year from this date.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The activity is available for credit through February 17, 2018.

Physician Assistant 

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

The activity is available for credit through February 17, 2018.

Nurse Practitioner

This activity is approved for 1.0 contact hours of continuing education (which includes 0.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17012485.

This activity was planned in accordance with AANP CE Standards and Policies. 

The activity is available for credit through February 17, 2018.

Dietitian

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

The activity is available for credit through February 17, 2018.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.     

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.00 AAFP Prescribed Credits
  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.50 CDR CPEUs
Course opens: 
02/17/2017
Course expires: 
02/17/2018
Cost:
$0.00
Rating: 
4
Disclosure of Investigational Use of Products:

This activity will include content about ZS-9, which has been submitted to the FDA for possible approval.

Faculty Disclosures:

Csaba P. Kovesdy, MD
Fred Hatch Professor of Medicine
University of Tennessee Health Science Center
Memphis, TN
Disclosure: Received honoraria from Relypsa and ZS Pharma as a consultant in the area of hyperkalemia, and from Astra Zeneca as a consultant in the area of anemia.

Edgar V. Lerma, MD
Clinical Professor of Medicine
University of Illinois Chicago
Associates in Nephrology, SC
Chicago, IL
Disclosure: Has no financial relationships with commercial interest(s). 

Planning Committee Disclosures:

Beth Evans, RN, MSN, CNP, DNP
Nephrology Nurse Practitioner
Renal Medicine Associates
Albuquerque, NM
Disclosure: Has no financial relationships with commercial interest(s).

Todd A. Thames, MD, MHA, FAAFP
Staff Physician
Grand Rounds, Inc.
San Francisco, CA
Disclosure: Has no financial relationships with commercial interest(s).

Nancy Mason, PharmD
Clinical Professor and Associate Dean
University of Michigan College of Pharmacy
Ann Arbor, MI
Disclosure: Is the owner of Renal Pharmacy Consultants.

Deborah Brommage, MS, RD, CSR, CDN
Senior Scientific Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Helbert Rondon-Berrios, MD
Assistant Professor Medicine
University of Pittsburgh
Pittsburgh, PA
Disclosure: Received an honoraria from Astute Medical, Inc. for his role as an advisory board member for an AKI biomarker test.

Dwayne Allen Pierce, BSPharm, PharmD, BCPS, FNKF
Pharmacy Clinical Coordinator
University of Kentucky Healthcare
Lexington, KY
Disclosure: Has no financial relationships with commercial interest(s).

Polly Gerber Zimmermann, RN, MS, MBA, CEN, FAEN
Associate Professor
Chicago City Colleges School of Nursing - Malcolm X Campus
Chicago, IL
Disclosure: Has no financial relationships with commercial interest(s).

Rachael R. Majorowicz, RDN, LD, FNKF
Renal Dietitian
Mayo Clinic
Rochester, MN
Disclosure: Spouse received an honoraria from Roche for involvement in a round table discussion in the area of laboratory medicine leadership.


This activity is supported by an educational grant from Relypsa.

Available Credit

  • 1.00 AAFP Prescribed Credits
  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.50 CDR CPEUs

Accreditation Period

Course opens: 
02/17/2017
Course expires: 
02/17/2018

Price

Cost:
$0.00

Enrollment Restricted

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals